Optimization of erlotinib plus sulindac dosing regimens for intestinal cancer prevention in an APC-mutant model of familial adenomatous polyposis (FAP) - Ulusan, A M; Rajendran, P; Dashwood, W M (Cancer Prev Res (Phila), 2021)